Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic Therapies

The company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date."

Wake Network Developing Genetics-Based Screening System to Offer Patients Personalized Psychedelic Therapies